Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study
2011

Obesity and Prostate Cancer Risk

Sample size: 1089 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dimitropoulou P, Martin R M, Turner E L, Lane J A, Gilbert R, Davis M, Donovan J L, Hamdy F C, Neal D E

Primary Institution: University of Cambridge

Hypothesis

Is obesity, as measured by BMI, waist circumference, and waist-to-hip ratio, associated with increased prostate cancer risk?

Conclusion

General adiposity, as measured by BMI, was associated with a decreased risk of low-grade PSA-detected prostate cancer.

Supporting Evidence

  • Obesity has been linked to various chronic diseases, including some cancers.
  • Previous studies have shown inconsistent associations between obesity and prostate cancer risk.
  • The study found no significant association between waist circumference or waist-to-hip ratio and prostate cancer.

Takeaway

Being overweight might actually lower the risk of some types of prostate cancer, but the effect is small.

Methodology

A case-control study using data from the ProtecT study, comparing prostate cancer cases with matched controls based on age and family history.

Potential Biases

Potential selection bias due to differences in the availability of obesity data between cases and controls.

Limitations

The study had a high percentage of missing data for BMI and waist measurements, which may affect the power to detect associations.

Participant Demographics

Men aged 50–69 years, with a higher proportion of cases reporting a family history of prostate cancer.

Statistical Information

P-Value

0.045

Confidence Interval

0.59, 0.97

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606066

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication